James M Allan

James M Allan

Newcastle University

H-index: 46

Europe-United Kingdom

About James M Allan

James M Allan, With an exceptional h-index of 46 and a recent h-index of 30 (since 2020), a distinguished researcher at Newcastle University, specializes in the field of cancer, genetics, leukaemia, precision medicine, therapy-induced cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Inherited cancer predisposing mutations in patients with therapy‐related myeloid neoplasms

Biallelic TET2 mutations confer sensitivity to 5′-azacitidine in acute myeloid leukemia

Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features

Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia

A Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Assay Identifies Nilotinib as an Inhibitor of Inflammation in Acute Myeloid Leukemia

hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia

Genome-wide association study identifies susceptibility loci for acute myeloid leukemia (vol 13, 2, 2022)

Human bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukaemia

James M Allan Information

University

Position

___

Citations(all)

9145

Citations(since 2020)

2668

Cited By

7572

hIndex(all)

46

hIndex(since 2020)

30

i10Index(all)

87

i10Index(since 2020)

56

Email

University Profile Page

Google Scholar

James M Allan Skills & Research Interests

cancer

genetics

leukaemia

precision medicine

therapy-induced cancer

Top articles of James M Allan

Inherited cancer predisposing mutations in patients with therapy‐related myeloid neoplasms

British Journal of Haematology

2023/2

A Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Assay Identifies Nilotinib as an Inhibitor of Inflammation in Acute Myeloid Leukemia

Journal of Medicinal Chemistry

2022/9/12

hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia

Cell Reports Medicine

2022/8/16

Human bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukaemia

bioRxiv

2021/6/18

Genome-Wide Association Analyses Identify Variants in IRF4 Associated With Acute Myeloid Leukemia and Myelodysplastic Syndrome Susceptibility

Frontiers in Genetics

2021/6/17

Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia

Nature Communications

2021/1/28

Meta-Analysis of Genome-Wide Association Studies of Acute Myeloid Leukemia (AML) Patients Identifies Variants Associated with Risk of 11q23/KMT2A-Translocated and Core-Binding …

2012/9/1

See List of Professors in James M Allan University(Newcastle University)

Co-Authors

academic-engine